Morgan Stanley’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$979K Sell
89,677
-1,459
-2% -$17.8K ﹤0.01% 5212
2026
Q1
$1.11M Sell
91,136
-10,339
-10% -$141K ﹤0.01% 5084
2025
Q4
$1.43M Sell
101,475
-112,030
-52% -$1.59M ﹤0.01% 5005
2025
Q3
$3.04M Buy
213,505
+94,347
+79% +$1.41M ﹤0.01% 4518
2025
Q2
$1.68M Buy
119,158
+24,872
+26% +$382K ﹤0.01% 4815
2025
Q1
$1.61M Sell
94,286
-24,842
-21% -$462K ﹤0.01% 4739
2024
Q4
$2.29M Buy
119,128
+55,936
+89% +$1.06M ﹤0.01% 4606
2024
Q3
$1.17M Sell
63,192
-79,149
-56% -$1.47M ﹤0.01% 4958
2024
Q2
$2.67M Buy
142,341
+92,497
+186% +$1.65M ﹤0.01% 4368
2024
Q1
$860K Sell
49,844
-12,038
-19% -$202K ﹤0.01% 5048
2023
Q4
$1.08M Buy
61,882
+2,029
+3% +$33.7K ﹤0.01% 4881
2023
Q3
$1.02M Buy
59,853
+19,282
+48% +$319K ﹤0.01% 4787
2023
Q2
$614K Sell
40,571
-20,290
-33% -$284K ﹤0.01% 5114
2023
Q1
$829K Buy
60,861
+29,086
+92% +$421K ﹤0.01% 4959
2022
Q4
$406K Sell
31,775
-156,917
-83% -$2.13M ﹤0.01% 5343
2022
Q3
$2.83M Sell
188,692
-9,142
-5% -$154K ﹤0.01% 4171
2022
Q2
$3.07M Buy
197,834
+29,876
+18% +$512K ﹤0.01% 4183
2022
Q1
$2.99M Buy
167,958
+137,812
+457% +$2.46M ﹤0.01% 4202
2021
Q4
$531K Buy
30,146
+29,302
+3,472% +$563K ﹤0.01% 5508
2021
Q3
$16K Buy
844
+35
+4% +$658 ﹤0.01% 7170
2021
Q2
$15K Sell
809
-23
-3% -$426 ﹤0.01% 7093
2021
Q1
$14K Hold
832
﹤0.01% 6838
2020
Q4
$12K Sell
832
-47
-5% -$645 ﹤0.01% 6583
2020
Q3
$11K Sell
879
-1,142
-57% -$14.3K ﹤0.01% 6238
2020
Q2
$26K Sell
2,021
-84,282
-98% -$970K ﹤0.01% 5930
2020
Q1
$833K Buy
+86,303
New +$1.19M ﹤0.01% 4082

Other funds holding CCAP

Morgan Stanley's CCAP Position: Q2 2026 in Review

Morgan Stanley reduced its Crescent Capital BDC (CCAP) stake by 1.6% in Q2 2026, selling an estimated $17.8K and leaving 89,677 shares worth $979K. The position accounts for ﹤0.01% of the portfolio, ranked #5212.

Morgan Stanley first reported a position in CCAP in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.07M in Q2 2022. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.

  • Morgan Stanley held 89,677 shares of Crescent Capital BDC worth $979K as of Q2 2026.
  • Morgan Stanley sold 1,459 Crescent Capital BDC shares in Q2 2026, an estimated $17.8K.
  • Crescent Capital BDC made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5212 holding.
  • Morgan Stanley first reported a position in Crescent Capital BDC in Q1 2020 and has held it in 26 quarters since.
  • Morgan Stanley's Crescent Capital BDC position peaked at $3.07M in Q2 2022.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.